This may explain why, in general, the tumor size/weight did not change significantly after WDR5 deficiency, and non-responders to chemotherapy/immunotherapy exhibited an even-higher WDR5 level compared with responders in colon-cancer and melanoma patients. This evidence concerns the gene WDR5 and neoplasm.